logiover/clinicaltrials-gov-scraper-sample-data

ClinicalTrials.gov Scraper

Scrape clinical trials from the official ClinicalTrials.gov API — no login, no API key, no blocking. 585K+ studies with status, phase, sponsor, conditions, interventions, enrollment, eligibility and locations. Filter by condition, sponsor and status. Tens of thousands per run.

What the actor scrapes

🔬 ClinicalTrials.gov Scraper — Clinical Trial Data from the Official API Scrape clinical trials straight from the official ClinicalTrials.gov API — no login, no API key, no blocking. This Apify Actor covers the full ClinicalTrials.gov database of 585,000+ studies worldwide, returning deep structured data: trial status, phase, sponsor, conditions, interventions, enrollment, eligibility, locations, and key dates. One run can return tens of thousands of trials. If you need bulk **clin

Who this is for

This sample is useful for anyone working in gov data, automation, developer tools who wants a quick look at the shape of the data before running the live actor at scale. Treat it as a static snapshot — counts, prices and timestamps reflect the moment the sample was captured and will drift over time.

Source

Live source: This dataset is a static sample. For fresh, customizable extractions, run the live Apify actor: logiover/clinicaltrials-gov-scraper

Fields

• nctId — identifier
• briefTitle — field captured by the actor
• officialTitle — field captured by the actor
• acronym — field captured by the actor
• organization — field captured by the actor
• overallStatus — field captured by the actor
• studyType — field captured by the actor
• phases — field captured by the actor
• enrollmentCount — numeric count
• leadSponsor — field captured by the actor
• sponsorClass — field captured by the actor
• collaborators — field captured by the actor
• conditions — field captured by the actor
• interventions — field captured by the actor
• briefSummary — field captured by the actor
• sex — field captured by the actor
• minimumAge — field captured by the actor
• maximumAge — field captured by the actor
• healthyVolunteers — field captured by the actor
• startDate — timestamp
• completionDate — timestamp
• primaryCompletionDate — timestamp
• firstPostedDate — timestamp
• lastUpdatePostedDate — timestamp
• locations — field captured by the actor
• hasResults — boolean flag
• url — canonical URL of the item
• scrapedAt — timestamp the row was scraped

Sample preview

[
  {
    "nctId": "NCT01213784",
    "briefTitle": "Optimized Glycemic Control in Heart Failure Patients With DM2:\"Effect on Left Ventricular Function and Skeletal Muscle\"",
    "officialTitle": "Optimized Glycemic Control in Type 2 Diabetics With Heart Failure:\"Effect on Left Ventricular Function and Skeletal Muscle\"",
    "acronym": "HFDM",
    "organization": "University of Aarhus",
    "overallStatus": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "phases": [
      "PHASE2"
    ],
    "enrollmentCount": 40,
    "leadSponsor": "University of Aarhus",
    "sponsorClass": "OTHER",
    "collaborators": [
      "The Danish Diabetes Association"
    ],
    "conditions": [
      "Type 2 Diabetes",
      "Heart Failure"
    ],
    "interventions": [
      "OTHER: all antidiabetic drugs will be appliable"
    ],
    "briefSummary": "The investigators wish to investigate wether a more strict diabetic control improves cardiac function, muscle strength, exercise capacity and decreases symptoms.\n\nThe investigators hypothesis is that improving the glycemic control in suboptimized diabetics with heart failure will improve cardiac performance, muscle strength, exercise capacity and decrease symptoms.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "90 Years",
    "healthyVolunteers": false,
    "startDate": "2010-09",
    "completionDate": "2012-11",
    "primaryCompletionDate": "2012-11",
    "firstPostedDate": "2010-10-04",
    "lastUpdatePostedDate": "2015-03-06",
    "locations": [
      {
        "facility": "Dept. of cardiology, Aarhus university hospital Skejby",
        "city": "Aarhus",
        "state": "Central Jutland",
        "country": "Denmark"
      }
    ],
    "hasResults": false,
    "url": "https://clinicaltrials.gov/study/NCT01213784",
    "scrapedAt": "2026-05-14T17:51:03.369Z"
  },
  {
    "nctId": "NCT03060538",
    "briefTitle": "A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease",
    "officialTitle": "A Phase Ib, Randomized, Blinded, Placebo-Controlled, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous BFKB8488A in Patients With Type 2 Diabetes Mellitus and Patients With Non-Alcoholic Fatty Liver Disease",
    "acronym": null,
    "organization": "Genentech, Inc.",
    "overallStatus": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "phases": [
      "PHASE1"
    ],
    "enrollmentCount": 154,
    "leadSponsor": "Genentech, Inc.",
    "sponsorClass": "INDUSTRY",
    "collaborators": [],
    "conditions": [
      "Diabetes Mellitus, Type 2",
      "Non-Alcoholic Fatty Liver Disease"
    ],
    "interventions": [
      "DRUG: BFKB8488A",
      "OTHER: Placebo"
    ],
    "briefSummary": "This is a Phase Ib, randomized, blinded, placebo-controlled, multiple ascending-dose study of the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) effects of BFKB8488A in participants with Type 2 diabetes mellitus (T2DM) and participants with non-alcoholic fatty liver disease(NAFLD). A maximum of approximately 160 participants will be enrolled across multiple sites in the Unite…",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "75 Years",
    "healthyVolunteers": false,
    "startDate": "2017-03-05",
    "completionDate": "2019-12-13",
    "primaryCompletionDate": "2019-12-13",
    "firstPostedDate": "2017-02-23",
    "lastUpdatePostedDate": "2020-03-27",
    "locations": [
      {
        "facility": "Pinnacle Research Group Cullman",
        "city": "Anniston",
        "state": "Alabama",
        "country": "United States"
      },
      {
        "facility": "Pinnacle Research Group; Llc, Central",
        "city": "Anniston",
        "state": "Alabama",
        "country": "United States"
      },
      {
        "facility": "Southern California Research Center, Inc.",
        "city": "Coronado",
        "state": "California",
        "country": "United States"
      },
      {
        "facility": "Stanford Health Care",
        "city": "Stanford",
        "state": "California",
        "country": "United States"
      },
      {
        "facility": "Diabetes Research Center",
        "city": "Tustin",
        "state": "California",
        "country": "United States"
      }
    ],
    "hasResults": false,
    "url": "https://clinicaltrials.gov/study/NCT03060538",
    "scrapedAt": "2026-05-14T17:51:03.463Z"
  }
]

Snapshot stats

• Row count in this sample: 100
• Data quality flag at capture time: EXISTING_USED

License & Attribution

Released under Creative Commons Attribution 4.0 (CC BY 4.0). If you use this data, please credit the source actor and link back to its Apify Store page: logiover/clinicaltrials-gov-scraper.

The sample is provided as-is for evaluation and research. Source websites retain their own terms of service — downstream users are responsible for complying with them when running the live actor or redistributing scraped content.